Posting of Circular and Notice of General Meeting
4basebio PLC has posted a circular to shareholders and called a General Meeting for November 6, 2026, to approve resolutions necessary for a proposed Capital Raise. The Directors unanimously recommend shareholders vote in favour of these resolutions, believing the Capital Raise is in the best interests of the Company and its shareholders. Completion of the Capital Raise is contingent upon the approval of these resolutions.
Select text to share a quote on X · sign in to keep highlights & notes in your 4BB notes
CAMBRIDGE, UK – 20 October 2026 - 4basebio PLC (AIM: 4BB), a specialist in synthetic DNA manufacturing for next-generation genomic medicines and advanced therapies, is pleased to provide a further update in relation to the proposed Capital Raise announced on 15 October 2026.
The Company has today posted to shareholders a circular convening the General Meeting required in connection with the Capital Raise (the “Circular”), at which shareholders will be asked to consider, and if thought fit, approve, the Resolutions set out in the Circular. Completion of the Capital Raise is conditional on approval of the Resolutions.
The General Meeting will be held at 10.00 a.m. on 6 November 2026 at the offices of Cooley (UK) LLP, 22 Bishopsgate, London EC2N 4BQ. A copy of the Circular is also available to view on the Company’s website, www.4basebio.com/investors.
Please note that shareholders intending to attend the General Meeting in person will need a QR code, displayed on a smartphone or similar device, to access the meeting venue. A QR code can be obtained in advance by emailing info@4basebio.com with your full name, full address and email address, or on arrival for shareholders who have not done so in advance.
The Directors are of the opinion that the proposed Capital Raise is in the best interests of the Company and its shareholders as a whole, and unanimously recommend that shareholders vote in favour of the Resolutions, as they intend to do in respect of their own beneficial holdings.
Capitalised terms in this announcement shall have the same meaning as set out in the Circular.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.